William Pao On Pfizer’s ‘Aspirational’ Drug Development Goal, Seagen And More
R&D Leader Met With Scrip At New Headquarters
Chief development officer William Pao oversees Pfizer’s clinical pipeline. He joined the company from Roche following a career in academia, and after his first year at Pfizer talked to Scrip about the transition to late-stage drug development.
